IPO Boutique

Applied Genetic Technologies Corp IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Applied Genetic Technologies Corp, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Applied Genetic Technologies CorpAGTC -
NASDAQ
$13.00-$15.00 $12.00 $12.754.2 million3/27/2014
BMO Capital Markets, Wedbush PacGrow Life Science
Co-Manager(s):
Cantor Fitzgerald & Co., Roth Capital Partners
Health Care
Filing(s):

Filed 2014-01-10
Terms Added 2014-03-12



Applied Genetic Technologies Corp Quote & Chart - Click for current quote - AGTC

About Applied Genetic Technologies Corp (adapted from Applied Genetic Technologies Corp prospectus):
They are a clinical-stage biotechnology company that uses our proprietary gene therapy platform to develop products designed to transform the lives of patients with severe inherited orphan diseases in ophthalmology.

This description is adapted from Applied Genetic AGTC prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as Applied Genetic AGTC "AGTC" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved